Life Science Reit Plc

-0.80 (-1.08%)
Share Name Share Symbol Market Type Share ISIN Share Description
Life Science Reit Plc LSE:LABS London Ordinary Share GB00BP5X4Q29 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -0.80 -1.08% 73.20 13,672 08:17:14
Bid Price Offer Price High Price Low Price Open Price
73.20 75.20 75.20 73.20 75.20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment Trust 15.71 -27.61 - - 256.20
Last Trade Time Trade Type Trade Size Trade Price Currency
08:17:21 O 4,862 74.20 GBX

Life Science Reit (LABS) Latest News

Life Science Reit (LABS) Discussions and Chat

Life Science Reit Forums and Chat

Date Time Title Posts
15/5/202307:35LIFE SCIENCE REIT111

Add a New Thread

Life Science Reit (LABS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Life Science Reit (LABS) Top Chat Posts

Top Posts
Posted at 15/5/2023 07:35 by jonwig
Letting at Cambridge:

10 years at £25/sqft. That looks low. London labs are £70 - £125, a lab at Oxford recently was £70. (Quick Google - no specialist knowledge.)

Posted at 14/4/2023 10:23 by gbcol
Chrisdgb, I haven’t picked up on any upcoming investor events for LABS, have you got any details? TIA.

For good or bad (and it’s not good ATM), I’ve got a fairly substantial holding in LABS now. Next month’s divi is going to be very decent though.

Posted at 23/3/2023 07:54 by jonwig
Report about shortage of lab space;

Trouble is, LABS isn't in a position to build anything.

Posted at 21/3/2023 10:50 by jonwig
Wasn't the "4%" based on the IPO price of 100p? (That's the usual way of saying these things.)

But if 4p isn't fully covered, it won't be so brilliant.

Posted at 21/3/2023 10:27 by saltwood
What will be interesting as we look forward to Monday’s results is, in addition to reassurance on the NAV and progress with OTP and reducing vacancy rates, is whether they stick to their dividend policy at IPO, namely a 4% dividend for year to Dec 2022. If so, we should be looking at a 3p per share dividend announced next week. Having re-read the results and listened again to a recent podcast from the investment manager, this trust appears to have done everything it said it would do at IPO and takes these commitments seriously. I am therefore really hopeful that the pain of recent months caused by broader market factors will be alleviated by a strong set of results next week. Here’s hoping!
Posted at 27/2/2023 07:26 by jonwig
New 10yr lease signed at OTP:

No money details given, unfortunately.

Also FY results 27 March, with live audio provided of presentation:

Posted at 13/2/2023 07:21 by jonwig
Looks like my #76 was only half the story:

A lack of laboratory space in Oxford and Cambridge threatens to thwart Rishi Sunak’s dream of making Britain a “science superpower”.

In both cities, there are almost no labs left for growing life sciences businesses to move into. Bidwells, the commercial property agent, estimates that there is 10,000 sq ft of space available in Cambridge, compared with two million sq ft of demand. There is a similar picture in Oxford, where there is about 25,000 sq ft available compared with requirements from businesses of 845,000 sq ft.

Developers are rushing through new projects to try to catch up with demand.

More -

Posted at 10/2/2023 08:24 by jonwig
The fall-out from Astra-Zeneca's announcement this week might have some effect. Other life science firms are warning that the UK is in danger of losing its self-proclaimed advantages by high corporation taxes.

LABS isn't a big enough player to be directly affected, I would think, but capital values might suffer and its NAV slip back.

Posted at 25/1/2023 09:26 by jonwig
This looks a decent letting:

But no rental amounts given initial yield, etc.

Posted at 18/1/2023 07:58 by jonwig
A rare piece of good news:

Quantum computing isn't life science, but we won't quibble!

Life Science Reit share price data is direct from the London Stock Exchange
Your Recent History
Life Scien..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230530 08:00:13